Clinical Trials Details

S1900A LUNGMAP - SUBSTUDY (Lung)

A Phase II Study of RUCAPARIB in Patients with Genomic LOH High and/or DELETERIOUS BRCA1/2 Mutation STAGE IV OR Recurrent Non-Small Cell Lung Cancer

Objective

This clinical trial was temporarily closed on July 16, 2020.

Clinical Trial Categories

  • Cancers and Other Neoplasms